Status:
COMPLETED
Effects of a Nutritional Solution to Improve Intestinal Permeability in Celiac Patients
Lead Sponsor:
Société Guaranteed Gluten Free (GGF)
Collaborating Sponsors:
Institut Polytechnique UniLaSalle
Institut Pasteur de Lille
Conditions:
Celiac Disease
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Celiac disease (or gluten intolerance) is recognized as one of the most common chronic diseases: prevalence of 1 in 100 to 1/300 people in Europe and the United States. To date, the treatment consists...
Eligibility Criteria
Inclusion
- celiac disease diagnosis at least 1 year ago
- diagnosis proven through biopsy report or general practioner letter or health insurance cover
- not following a strict gluten free diet (Pavie score 1-3)
- covered by health insurance
- not in exclusion period from another study
Exclusion
- pregnant, breastfeeding women or planing pregnancy
- gluten intolerance of non celiac origin or any other dietary intolerance of allergy
- digestive pathology other than celiac disease
- chronic transit problems (diarrhoea or constipation)
- uncontrolled pathology
- diabetes
- medical treatment impacting outcome markers (corticosteroids, NSAIDS, immune suppressor drugs, pancreatic enzymes, amphetamines)
- recent or regular intake of prebiotics, probiotics, food supplements including B vitamins, iron or calcium.
- antibiotics in the past month
- excessive alcohol intake
- drug user
- planing to change tobacco use
- any other reason why the investigator feels the subject may not be compliant
- adults under judicial protection
Key Trial Info
Start Date :
December 21 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 12 2018
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT03483805
Start Date
December 21 2016
End Date
January 12 2018
Last Update
April 20 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Pasteur de Lille
Lille, France